Hemos Bioscience

Hemos Bioscience

Global leader in recombinant humanized keratin biomaterials

About Hemos Global leader in recombinant humanized keratin biomaterials

HEMOS (Chongqing) Bioscience Co., LTD. was established in 2017 and is headquartered in Chongqing. It is a biotechnology company specializing in the research, development, production, and sales of Recombinant Humanized Keratin. Relying on the research team led by Professors Wang Bochu and Hao Shilei from the Bioengineering College of Chongqing University, the company has been deeply engaged in the field of recombinant humanized keratin for over a decade. The research team has successfully deciphered and reconstructed the functional gene sequence of human keratin. Leveraging synthetic biology technologies, the company has become the first one in the world to achieve large-scale production of recombinant humanized keratin.
2017 year

Hemos Bioscience Established

40 +item

Invention Patent and Technology

95 %+

SCI Papers in the Global Recombinant Humanized Keratin Field

View details →

Product / Service We specialize in providing high-performance biomaterials and solutions for the beauty & personal care (oral care, skincare, hair care) and biomedical fields.

Core Strengths Relying on independent R&D and full-industry-chain integration to achieve large-scale, standardized production.

Senior Scientist Team

Bringing together top-tier scientists in the field of biomedical engineering, we have been deeply engaged in the Recombinant Humanized Keratin field for over a decade, accumulating more than 40 authorized patents and over 100 research achievements. Our global share of SCI papers exceeds 95%, placing us among the industry leaders in research strength.

Advanced preparation process

Using genetic engineering technology, our process circumvents the quality defects inherent in traditional processes and represents a monumental leap forward in keratin preparation technology worldwide over the past century and more.

Large-scale production capacity

Compliant with the ISO9001 production quality system, our production system ensures high-quality, highly stable mass production of Recombinant Humanized Keratin and builds a complete “raw material-to-application” industrial chain with significant cost advantages.

Innovative R&D Exploring the infinite possibilities of biomanufacturing through synthetic biology

Recombinant Keratin → R&D platform → Leading-edge View →

Develop innovative biomaterials centered on synthetic biology to drive the innovative applications and industrial upgrading of keratin across diverse fields.

Build an advanced synthetic biology platform for the R&D and industrialization of recombinant keratin, and continuously drive technological iteration and industry innovation.

News and Information